Lehmann-Horn F, Sipos I, Jurkat-Rott K, Heine R, Brinkmeier H, Fontaine B, Kovacs L, Melzer W
Department of Applied Physiology, University of Ulm, Germany.
Soc Gen Physiol Ser. 1995;50:101-13.
In a genome-wide search, linkage of hypokalemic periodic paralysis (HypoPP), a muscle disease with autosomal dominant inheritance, to chromosome 1q31-32 and cosegregation with the gene encoding the L-type calcium channel/DHP receptor alpha 1 subunit has been reported (Fontaine et al., 1994). Here we show the extended haplotypes of a large HypoPP family who made the detection of the gene product possible. Sequencing of cDNA synthesized from RNA isolated from muscle specimens of two affected family members revealed a G-to-A transition of nucleotide 3716. This base exchange predicts a substitution of histidine for arginine 1239 located in segment IVS4 of the channel protein. By restriction fragment analysis, the mutation was detected in the genomic DNA of all affected family members. Myotubes cultured from the muscle specimens also revealed the mutation suggesting the expression of mutant L-type calcium channel/DHP receptors. Whole-cell recordings of 20 such myotubes showed a strong reduction of the DHP sensitive, slowly activating and inactivating L-type current density to 30% of the current in normal controls. A rapidly activating and inactivating current component (third-type), which is distinct from the also occurring T-type current, was increased. We conclude that HypoPP is a disease of the skeletal muscle DHP receptor. The point mutation in repeat IV of the protein may have a similar effect as drugs which downregulate the channel activity by binding to this domain.
在一项全基因组搜索中,已报道常染色体显性遗传的肌肉疾病低钾性周期性麻痹(HypoPP)与1q31 - 32染色体连锁,并与编码L型钙通道/DHP受体α1亚基的基因共分离(方丹等人,1994年)。在此,我们展示了一个大型HypoPP家族的扩展单倍型,这使得对基因产物的检测成为可能。对从两名患病家族成员的肌肉标本中分离的RNA合成的cDNA进行测序,发现核苷酸3716发生了G到A的转变。这种碱基交换预测通道蛋白IVS4区段中的精氨酸1239被组氨酸取代。通过限制性片段分析,在所有患病家族成员的基因组DNA中检测到了该突变。从肌肉标本培养的肌管也显示出该突变,表明突变型L型钙通道/DHP受体的表达。对20个这样的肌管进行全细胞记录显示,DHP敏感的、缓慢激活和失活的L型电流密度大幅降低至正常对照电流的30%。一种快速激活和失活的电流成分(第三型)增加了,它与也存在的T型电流不同。我们得出结论,HypoPP是一种骨骼肌DHP受体疾病。该蛋白重复序列IV中的点突变可能与通过结合该结构域而下调通道活性的药物具有相似的作用。